Recently, aberrant rapidly accelerated fibrosarcoma (Raf) /mitogen-activated protein kinase, MEK/extracellular signal-regulated kinase, and ERK signaling pathway activation have been identified as central for cancer growth, motility, and survival. This evidence concerns the gene MAP2K7 and cancer.